- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06497335
Accuracy of Non Invasive Hemoglobin Measure by SpHb Device in Post Operative Anemia Diagnosis (SpHb_gyneco)
July 4, 2024 updated by: University Hospital, Angers
Accuracy of Non Invasive Hemoglobin Measure by SpHb Device in Post Operative Anemia Diagnosis: a Validation Study in Gynecological Surgery Department of Angers 's University Hospital
Non invasive Hemoglobin monitoring by SpHb device had been developed to assess Hemoglobin level during hemorrhagic surgery.
It's accuracy to detect post operative anemia on a single post operative measure has been recently demonstrated on a cohort of post operative orthopedic patient and it's routine use has been generalized to other surgical department.
This study aims to valid these finding on a cohort of post operative patients from gynaecological department.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
150
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Elise Houssin
- Phone Number: +33 02 41 35 36 37
- Email: DRCI-Promotion-Interne@chu-angers.fr
Study Contact Backup
- Name: Sigismond Lasocki
- Phone Number: +33 02/41/35/36/37
- Email: SiLasocki@chu-angers.fr
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
population of gynecological surgical department
Description
Inclusion Criteria:
- being hospitalized for gynecological procedure: hysterectomy or cancer related annexectomy
- > 18 years
Exclusion Criteria:
- non french speaker
- being under a legal individual protection measure
- not being able to consent
- being opposed to data collection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
accuracy between SpHb measure and Hemoglobin level on the post operative blood sample
Time Frame: at 2 and 8 months after establishment of PBM protocol
|
level of immediate post operative SpHb measure compared to blood hemoglobin measure, ROC curve
|
at 2 and 8 months after establishment of PBM protocol
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Spearman correlation coefficient
Time Frame: at 2 and 8 months after establishment of PBM protocol
|
correlation between Laboratory Hb and SpHb measure
|
at 2 and 8 months after establishment of PBM protocol
|
|
Kappa coefficient
Time Frame: at 2 and 8 months after establishment of PBM protocol
|
correlation between SpHb measure and correct classification of patients anemia vs no anemia
|
at 2 and 8 months after establishment of PBM protocol
|
|
Intra class correlation coefficient
Time Frame: at 2 and 8 months after establishment of PBM protocol
|
correlation between Laboratory measurement and SpHb measurement
|
at 2 and 8 months after establishment of PBM protocol
|
|
Subgroup analysis of ROC curve (classes of age 18-30; 30-40; 40-50; >50)
Time Frame: at 2 and 8 months after establishment of PBM protocol
|
comparison of ROC curve areas in subgroups
|
at 2 and 8 months after establishment of PBM protocol
|
|
impact of body temperature on accuracy of SpHb
Time Frame: at 2 and 8 months after establishment of PBM protocol
|
comparison of ROC curve areas in subgroups of temperature (classes of temperature : <35; 35-36; >36)
|
at 2 and 8 months after establishment of PBM protocol
|
|
impact of perfusion index on accuracy of SpHb
Time Frame: at 2 and 8 months after establishment of PBM protocol
|
comparison of ROC curve areas in subgroups of perfusion index (good or low perfusion index)
|
at 2 and 8 months after establishment of PBM protocol
|
|
impact of leght between SpHb measurement and laboratory Hb measurement on accuracy
Time Frame: at 2 and 8 months after establishment of PBM protocol
|
comparison of ROC curve areas in subgroups of lenght in days between SpHb measurement and Laboratory Hb measurement
|
at 2 and 8 months after establishment of PBM protocol
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sigismond Lasocki, University Hospital, Angers
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 30, 2024
Primary Completion (Estimated)
January 1, 2026
Study Completion (Estimated)
January 1, 2026
Study Registration Dates
First Submitted
June 18, 2024
First Submitted That Met QC Criteria
July 4, 2024
First Posted (Actual)
July 11, 2024
Study Record Updates
Last Update Posted (Actual)
July 11, 2024
Last Update Submitted That Met QC Criteria
July 4, 2024
Last Verified
June 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 24_0206
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anemia
-
Hospital Universitario Dr. Jose E. GonzalezCompletedPernicious Anemia | Megaloblastic Anemia NosMexico
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingSevere Aplastic Anemia | Idiopathic Aplastic Anemia | Moderate Aplastic Anemia Requiring Transfusions
-
Institute of Hematology & Blood Diseases Hospital...Not yet recruitingSevere Aplastic Anemia | Refractory Aplastic Anemia | Newly Diagnosed Aplastic Anemia
-
SanofiActive, not recruitingWarm Autoimmune Hemolytic Anemia (wAIHA)United States, Austria, China, Denmark, Germany, Italy, Spain, United Kingdom, Hungary
-
SanofiTerminatedWarm Autoimmune Hemolytic Anemia (wAIHA)Netherlands, Germany, Italy, United Kingdom, United States, France
-
China Immunotech (Beijing) Biotechnology Co., Ltd.Not yet recruitingAutoimmune Hemolytic AnemiaChina
-
Peking Union Medical College HospitalNot yet recruiting
-
Chinese PLA General HospitalBeijing Friendship Hospital; Beijing 302 Hospital; The University of Hong Kong-Shenzhen... and other collaboratorsEnrolling by invitationSevere Aplastic Anemia | Severe Aplastic Anemia (SAA) | Severe Aplastic Anemia, RefractoryChina
-
Incyte CorporationTerminatedWarm Autoimmune Hemolytic Anemia (wAIHA)Spain, United States, Austria, Canada, France, Germany, Israel, Italy, Japan, Netherlands, Poland, United Kingdom, Belgium
-
Chen MiaoNot yet recruiting
Clinical Trials on non invasive hemoglobin measure
-
Beth Israel Deaconess Medical CenterBaxter Healthcare CorporationTerminatedSeptic Shock | Infection | Congestive Heart Failure | Hypovolemia | Acute Heart Failure | HypervolemiaUnited States
-
Respiree Pte LtdNot yet recruiting
-
George Washington UniversityCompletedPregnancy, High RiskPakistan, Zambia, Kenya
-
Centre Hospitalier Intercommunal de Toulon La Seyne...CompletedAcute Respiratory Distress SyndromeFrance
-
Samuel Lunenfeld Research Institute, Mount Sinai...Completed
-
Bulent Ecevit UniversityCompletedHemorrhage | Bleeding | Hemodynamic InstabilityTurkey
-
University of Las Palmas de Gran CanariaRecruiting
-
Aníbal Báez SuárezCompleted
-
University of Las Palmas de Gran CanariaCompletedAutism Spectrum DisorderSpain
-
University of Las Palmas de Gran CanariaCompleted